GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (NAS:CRON) » Definitions » Shiller PE Ratio

CRON (Cronos Group) Shiller PE Ratio : 97.50 (As of Dec. 11, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cronos Group Shiller PE Ratio?

As of today (2024-12-11), Cronos Group's current share price is $1.95. Cronos Group's E10 for the quarter that ended in Sep. 2024 was $0.02. Cronos Group's Shiller PE Ratio for today is 97.50.

The historical rank and industry rank for Cronos Group's Shiller PE Ratio or its related term are showing as below:

CRON' s Shiller PE Ratio Range Over the Past 10 Years
Min: 58.5   Med: 101   Max: 168.5
Current: 97.5

During the past years, Cronos Group's highest Shiller PE Ratio was 168.50. The lowest was 58.50. And the median was 101.00.

CRON's Shiller PE Ratio is ranked worse than
94.84% of 465 companies
in the Drug Manufacturers industry
Industry Median: 26.72 vs CRON: 97.50

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cronos Group's adjusted earnings per share data for the three months ended in Sep. 2024 was $0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.02 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cronos Group Shiller PE Ratio Historical Data

The historical data trend for Cronos Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cronos Group Shiller PE Ratio Chart

Cronos Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 97.65

Cronos Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.56 97.65 133.87 131.75 106.23

Competitive Comparison of Cronos Group's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cronos Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cronos Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cronos Group's Shiller PE Ratio falls into.



Cronos Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cronos Group's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1.95/0.02
=97.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cronos Group's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Cronos Group's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.02/127.2847*127.2847
=0.020

Current CPI (Sep. 2024) = 127.2847.

Cronos Group Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.000 98.367 0.000
201503 -0.016 99.789 -0.020
201506 -0.016 100.500 -0.020
201509 -0.007 100.421 -0.009
201512 0.038 99.947 0.048
201603 -0.008 101.054 -0.010
201606 -0.031 102.002 -0.039
201609 -0.003 101.765 -0.004
201612 0.009 101.449 0.011
201703 -0.007 102.634 -0.009
201706 0.001 103.029 0.001
201709 0.008 103.345 0.010
201712 -0.013 103.345 -0.016
201803 -0.008 105.004 -0.010
201806 0.003 105.557 0.004
201809 -0.031 105.636 -0.037
201812 -0.089 105.399 -0.107
201903 0.330 106.979 0.393
201906 0.160 107.690 0.189
201909 1.620 107.611 1.916
201912 0.160 107.769 0.189
202003 0.200 107.927 0.236
202006 -0.310 108.401 -0.364
202009 0.180 108.164 0.212
202012 -0.320 108.559 -0.375
202103 -0.440 110.298 -0.508
202106 -0.480 111.720 -0.547
202109 0.210 112.905 0.237
202112 -0.360 113.774 -0.403
202203 -0.090 117.646 -0.097
202206 -0.050 120.806 -0.053
202209 -0.100 120.648 -0.106
202212 -0.210 120.964 -0.221
202303 -0.050 122.702 -0.052
202306 -0.020 124.203 -0.020
202309 -0.004 125.230 -0.004
202312 -0.110 125.072 -0.112
202403 -0.010 126.258 -0.010
202406 -0.020 127.522 -0.020
202409 0.020 127.285 0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cronos Group  (NAS:CRON) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cronos Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cronos Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cronos Group Business Description

Traded in Other Exchanges
Address
111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Executives
Kamran Khan director 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Elizabeth Seegar director 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Dominik Meier director 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Jason Marc Adler director 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2G9
Mcginness James Andrew Iii officer: VP, Controller C/O MARKETWISE, 1125 N. CHARLES STREET, BALTIMORE MD 21201
Maple Holdco (bermuda) Ltd. 10 percent owner C/O ALTRIA GROUP, INC., 6601 WEST BROAD STREET, RICHMOND VA 23230
Maple Acquireco (canada) Ulc 10 percent owner C/O ALTRIA GROUP, INC., 6601 WEST BROAD STREET, RICHMOND VA 23230
Altria Summit Llc 10 percent owner C/O ALTRIA GROUP, INC., 6601 WEST BROAD STREET, RICHMOND VA 23230
Altria Group, Inc. 10 percent owner 6601 WEST BROAD STREET, RICHMOND VA 23230
James Holm officer: Chief Financial Officer 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Arye Weigensberg officer: See Remarks 111 PETER STREET, SUITE 300, TORONTO A6 MV5 2H1
Doucet Terrence Gregory Joseph officer: See Remarks 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
John Griese officer: See Remarks 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Ran Gorelik officer: General Manager (Israel) 111 PETER STREET, SUITE 300, TORONTO A6 M5V 2H1
Robert L Madore officer: Chief Financial Officer C/O RALPH LAUREN CORPORATION, 650 MADISON AVENUE, NEW YORK NY 10022